Vimarsana
Biggest News Aggregation in the World

Daniela Eltrop News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Daniela Eltrop. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Daniela Eltrop Today - Breaking & Trending Today

QIAGEN N : Form 6-K - Vimarsana News

QIAGEN N : Form 6-K

QIAGEN N.V. By: /s/ Roland... -Today at 06:08 am- MarketScreener

QIAGEN expands range of digital PCR kits and services for the biopharma industry - Vimarsana News

QIAGEN expands range of digital PCR kits and services for the biopharma industry

Venlo, the Netherlands, July 18, 2023 -- QIAGEN announced today the expansion of its digital PCR offering for the development of cell and gene therapies in the biopharma industry. The company...

FBI approves QIAGEN's NGS-based ForenSeq MainstAY workflow for the U.S. National DNA Index System (NDIS) - Qiagen (NYSE:QGEN) - Vimarsana News

FBI approves QIAGEN's NGS-based ForenSeq MainstAY workflow for the U.S. National DNA Index System (NDIS) - Qiagen (NYSE:QGEN)

Venlo, the Netherlands, and San Diego, California, June 20, 2023 (GLOBE NEWSWIRE) -- QIAGEN (NYSE:QGEN, Frankfurt Prime Standard: QIA)) announced today that the U.S. Federal Bureau of Investigation (FBI) has approved

FBI approves QIAGEN's NGS-based ForenSeq MainstAY workflow for the U.S. National DNA Index System (NDIS) - Vimarsana News

FBI approves QIAGEN's NGS-based ForenSeq MainstAY workflow for the U.S. National DNA Index System (NDIS)

NDIS approval provides access to federal government funding for accredited public crime laboratories in the U.S. to implement next-generation sequencing for routine casework // NGS-based ForenSeq... | June 20, 2023

QIAGEN's QuantiFERON-TB Gold Plus shows unique clinical value with CD8 technology in new meta-analysis of tuberculosis screening - Vimarsana News

QIAGEN's QuantiFERON-TB Gold Plus shows unique clinical value with CD8 technology in new meta-analysis of tuberculosis screening

Venlo, the Netherlands, June 15, 2023 -- QIAGEN welcomes the publication of a new, systematic review highlighting the unique value of its proprietary tuberculosis testing technology. The study... | June 15, 2023